ISPE

JULY 5, 2023

This article discusses how US regulators addressed the regulatory hurdles related to CM to broaden its adoption through engagement, regulatory science, guidance, and international harmonization. 2 , 3 Key differences between CM of pharmaceuticals versus other chemicals relate primarily to volume and runtime.

FDA 52

FDA Dosage Documentation Pharmaceutical Companies 52

The Thyroid Pharmacist

OCTOBER 28, 2022

Discovering the right type of probiotics was an important part of healing my own gut, and in this article, I’d like to share more information about: The root causes of intestinal permeability. 2022 Jul 04;12(7):]. Unique dysbiosis patterns in Hashimoto’s. Sources of probiotic-rich foods. Different types of probiotics. Life (Basel).

Health and Personal Care Stores 105

Health and Personal Care Stores Immunization Grocery Stores Compounding 105

The Thyroid Pharmacist

OCTOBER 27, 2023

3] You can learn more about the HPA axis and adrenals here in the linked article. These signals create communication and function within nerves and muscles, as the electrolytes move in or out of cells. Humic extract, the main ingredient, contains fulvate, which helps the cells in our gut better communicate with each other and bacteria.

Health and Personal Care Stores 66

Health and Personal Care Stores Immunization Compounding Packaging 66

ISPE

MARCH 7, 2023

link] As emphasized at the recent UN Climate Change Conference COP27 (held at the end of 2022 in Sharm el-Sheik, Egypt), international focus is now on implementation. 3 , 4 Most companies have some existing initiatives underway, but many do not yet have a fully comprehensive and integrated program. October 2015. link] 2 United Nations.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

MARCH 6, 2023

link] A recent study published by My Green Lab 2 presented data from 74 biotechnology and pharmaceutical companies tracking the change in scope 1, 2, and 3 carbon intensity (measured in tons of CO2 emitted vs. the company’s revenue in USD) since 2015. Revised November 2022. Accessed November 2022. link] Source 11.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52

ISPE

MAY 9, 2023

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. Decree 334/2022. “By Published 13 May 2021.

Documentation 52

Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

MARCH 7, 2023

This article reviews two case studies that cover sustainable pack types and extension of shelf life. The Global Use of Medicines 2022.” Increasing the Circularity of Packaging Along Pharmaceuticals Value Chain.” 8 (2022): 4715–4731. The Pharmaceutical Industry in Figures. Key Data 2022.” 9 December 2021.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

ISPE

SEPTEMBER 10, 2023

In this article, we describe the assessment of lag time for global regulatory approvals of postapproval CMC changes for multiple products over a three-year period. Pharmaceutical Engineering 42, no. 1 (January/February 2022). link] 6 International Pharmaceutical Regulators Programme. Cauchon, T. Hedberg, M. Lepore, et al.

Documentation 98

Documentation Process Improvement Packaging Pharmaceutical Companies 98